Haemonetics Corporation (HAE)

Healthcare | Medical Instruments Supplies
Income Statement (Quarterly) 2025-06-28 2025-03-29 2024-12-28 2024-09-28
Revenue 321,394,000 330,599,000 348,542,000 345,511,000
Cost of Revenue 140,927,000 137,549,000 154,995,000 158,074,000
Gross Profit 180,467,000 193,050,000 193,547,000 187,437,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 109,753,000 115,360,000 106,459,000 106,946,000
Operating Expenses 125,329,000 131,274,000 134,518,000 135,740,000
Operating Income 55,138,000 71,335,000 59,029,000 51,697,000
Interest Expense 4,073,000 -598,000 9,112,000 6,993,000
Income Before Tax 45,169,000 70,737,000 49,917,000 44,704,000
Income Tax Expense 11,138,000 12,756,000 12,423,000 10,873,000
Net Income 34,031,000 57,981,000 37,494,000 33,831,000
Per Share
EPS 0.71 1.17 0.75 0.66
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-03-29 2024-03-30 2023-04-01 2023-03-31 2022-04-02
Revenue 1,360,824,000 1,309,055,000 1,168,660,000 1,168,660,000 993,196,000
Cost of Revenue 611,866,000 617,507,000 553,563,000 553,563,000 487,694,000
Gross Profit 748,958,000 691,548,000 615,097,000 615,097,000 505,502,000
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 436,789,000 431,780,000 376,675,000 376,675,000 339,563,000
Operating Expenses 527,141,000 526,665,000 459,064,000 459,064,000 433,778,000
Operating Income 221,817,000 164,883,000 156,033,000 156,033,000 80,750,000
Interest Expense 9,746,000 13,018,000 14,630,000 14,630,000 17,121,000
Income Before Tax 212,071,000 151,865,000 141,403,000 141,403,000 63,629,000
Income Tax Expense 44,392,000 34,307,000 26,002,000 26,002,000 20,254,000
Net Income 167,679,000 117,558,000 115,401,000 115,401,000 43,375,000
Per Share
EPS 3.31 2.32 2.27 0.00 0.85
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-03-29 2024-03-31 2024-03-30 2023-04-01
Assets
Cash and Cash Equivalents 306,763,000 178,800,000 178,800,000 284,466,000
Short Term Investments 0 0 0 1,110,000
Net Receivables 202,657,000 206,562,000 206,562,000 179,142,000
Inventory 365,141,000 317,202,000 317,202,000 259,379,000
Total Current Assets 934,975,000 768,903,000 768,903,000 769,722,000
Property Plant Equipment 284,052,000 311,362,000 366,630,000 310,885,000
Goodwill and Intangibles 1,060,011,000 971,199,000 971,199,000 742,002,000
Total Assets 2,450,948,000 2,195,591,000 2,195,591,000 1,934,825,000
Liabilities
Account Payables 66,999,000 0 73,358,000 63,929,000
Short Term Debt 303,558,000 10,229,000 10,229,000 11,784,000
Total Current Liabilities 578,113,000 300,383,000 300,383,000 251,816,000
Long Term Debt 921,230,000 797,564,000 797,564,000 754,102,000
Total Liabilities 1,630,112,000 1,235,632,000 1,235,632,000 1,116,828,000
Shareholders Equity
Retained Earnings 352,174,000 0 360,456,000 253,168,000
Total Shareholders Equity 820,836,000 959,959,000 959,959,000 817,997,000
Balance Sheet (Annual) 2025-03-29 2024-03-31 2024-03-30 2023-04-01 2023-03-31
Assets
Cash and Cash Equivalents 306,763,000 178,800,000 178,800,000 284,466,000 284,466,000
Short Term Investments 0 0 0 1,110,000 0
Net Receivables 202,657,000 206,562,000 206,562,000 179,142,000 179,142,000
Inventory 365,141,000 317,202,000 317,202,000 259,379,000 259,379,000
Total Current Assets 934,975,000 768,903,000 768,903,000 769,722,000 769,722,000
Property Plant Equipment 284,052,000 311,362,000 366,630,000 310,885,000 310,885,000
Goodwill and Intangibles 1,060,011,000 971,199,000 971,199,000 742,002,000 742,002,000
Total Assets 2,450,948,000 2,195,591,000 2,195,591,000 1,934,825,000 1,934,825,000
Liabilities
Account Payables 66,999,000 0 73,358,000 63,929,000 0
Short Term Debt 303,558,000 10,229,000 10,229,000 11,784,000 11,784,000
Total Current Liabilities 578,113,000 300,383,000 300,383,000 251,816,000 251,816,000
Long Term Debt 921,230,000 797,564,000 797,564,000 754,102,000 754,102,000
Total Liabilities 1,630,112,000 1,235,632,000 1,235,632,000 1,116,828,000 1,116,828,000
Shareholders Equity
Retained Earnings 352,174,000 0 360,456,000 253,168,000 0
Total Shareholders Equity 820,836,000 959,959,000 959,959,000 817,997,000 817,997,000
Cash Flow Statement (Quarterly) 2025-03-29 2024-03-30 2023-04-01 2023-03-31
Operating Activities
Net Income 167,679,000 117,558,000 115,401,000 115,401,000
Depreciation & Amortization 115,586,000 97,215,000 93,307,000 93,307,000
Stock Based Compensation 29,636,000 28,332,000 25,583,000 25,583,000
Change in Working Capital -101,962,000 -74,701,000 25,503,000 25,503,000
Operating Cash Flow 181,725,000 181,751,000 273,058,000 273,058,000
Investing Activities
Capital Expenditure -39,278,000 -66,296,000 -110,191,000 -110,191,000
Investments -39,278,000 -66,296,000 -110,191,000 -110,191,000
Investing Cash Flow -161,895,000 -322,389,000 -143,788,000 -143,788,000
Financing Activities
Debt Repayment 447,312,000 37,750,000 -9,625,000 -9,625,000
Common Stock Issued/Repurchased -225,000,000 0 -67,984,000 -75,000,000
Dividends Paid 0 0 0 0
Financing Cash Flow 108,818,000 38,157,000 -100,364,000 -100,364,000
Summary
Free Cash Flow 142,447,000 115,455,000 162,867,000 162,867,000
Net Change in Cash 127,963,000 -105,666,000 24,970,000 24,970,000
Cash Flow Statement (Annual) 2025-03-29 2024-03-30 2023-04-01 2023-03-31 2022-04-02
Operating Activities
Net Income 167,679,000 117,558,000 115,401,000 115,401,000 43,375,000
Depreciation & Amortization 115,586,000 97,215,000 93,307,000 93,307,000 97,747,000
Stock Based Compensation 29,636,000 28,332,000 25,583,000 25,583,000 24,359,000
Change in Working Capital -101,962,000 -74,701,000 25,503,000 25,503,000 -15,177,000
Operating Cash Flow 181,725,000 181,751,000 273,058,000 273,058,000 172,263,000
Investing Activities
Capital Expenditure -39,278,000 -66,296,000 -110,191,000 -110,191,000 -96,509,000
Investments -39,278,000 -66,296,000 -110,191,000 -110,191,000 -96,509,000
Investing Cash Flow -161,895,000 -322,389,000 -143,788,000 -143,788,000 -86,345,000
Financing Activities
Debt Repayment 447,312,000 37,750,000 -9,625,000 -9,625,000 -17,500,000
Common Stock Issued/Repurchased -225,000,000 0 -67,984,000 -75,000,000 6,547,000
Dividends Paid 0 0 0 0 0
Financing Cash Flow 108,818,000 38,157,000 -100,364,000 -100,364,000 -15,749,000
Summary
Free Cash Flow 142,447,000 115,455,000 162,867,000 162,867,000 75,754,000
Net Change in Cash 127,963,000 -105,666,000 24,970,000 24,970,000 67,191,000